Retrospective Descriptive Analysis of Metformin with Atezolizumab in Advanced Non-Small Cell Lung Cancer in The OAK Trial

被引：10
|
作者：
Pietras, R. [1 ,2 ]
Xu, H. [3 ]
Hu, X. [3 ]
Matheny, C. [3 ]
Sandler, A. [3 ]
Patel, M. [4 ]
机构：
[1] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
[2] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Minnesota, Hematol Oncol Transplant, Minneapolis, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
metformin; atezolizumab; NSCLC;
D O I：
10.1016/j.jtho.2018.08.748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-33
引用
收藏
页码：S538 / S539
页数：2
相关论文
共 50 条
  • [1] Atezolizumab in advanced non-small cell lung cancer
    Ilie, Marius
    Hofman, Paul
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3603 - 3606
  • [2] A retrospective, descriptive analysis identifying non-small cell lung cancer molecular markers
    Shafiq, Irfan
    Isse, Said
    Khan, Naureen
    Uzebeck, Mateen
    Zoumot, Zaid
    Shabeer, Safia
    Wahla, Ali
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (06)
  • [3] Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer
    Hannah A. Blair
    Targeted Oncology, 2018, 13 : 399 - 407
  • [4] Atezolizumab: A Review in Previously Treated Advanced Non-Small Cell Lung Cancer
    Blair, Hannah A.
    TARGETED ONCOLOGY, 2018, 13 (03) : 399 - 407
  • [5] Real-World Efficacy and Safety of Atezolizumab for Advanced Non-Small Cell Lung Cancer in Japan: A Retrospective Multicenter Analysis
    Okada, Masahiko
    Ohgino, Keiko
    Horiuchi, Kohei
    Sayama, Koichi
    Arai, Daisuke
    Watase, Mayuko
    Kobayashi, Keigo
    Terashima, Takeshi
    Ishioka, Kota
    Miyawaki, Masayoshi
    Sakamaki, Fumio
    Masuzawa, Keita
    Terai, Hideki
    Yasuda, Hiroyuki
    Soejima, Kenzo
    Fukunaga, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [6] Atezolizumab for the treatment of non-small cell lung cancer
    Santini, Fernando C.
    Rudin, Charles M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (09) : 935 - 945
  • [7] The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial
    Wang, Jijin
    Huang, Di
    Yang, Wenjing
    Song, Qingxu
    Jia, Yibin
    Chen, Pengxiang
    Cheng, Yufeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] A Nomogram to Predict Survival in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab: An Analysis of OAK and POPLAR Cohorts
    Shang, X.
    Shi, J.
    Wang, X.
    Yu, H.
    Zhao, C.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S248 - S248
  • [9] Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study
    Wang, Yuyang
    Zhu, Jingjuan
    Zhou, Na
    Wang, Yun
    Zhang, Xiaochun
    JOURNAL OF THORACIC DISEASE, 2023, 15 (10) : 5669 - 5679
  • [10] Atezolizumab in advanced non-small-cell lung cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2017, 18 (08): : E434 - E434
12345